NCT07282860
An Evaluation of the PureWick™ Male External Catheter Versus an Established Comparator Overnight in the Home Setting for Incontinence in Adult Males
Completed
NAAges 18+InterventionalSupportive careC. R. Bard
~120 participants
Updated 2026-08-04 on ClinicalTrials.gov
What's tested:PureWick SystemUltraFlex Self-Adhering Male External Catheter
At a glance
Recruiting sites
0 of 15 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Capture rate following void (captured as % of urine captured by device and collected in canister, measured by weight).
Measured over From enrollment up to 14 days of treatment
Conditions
Where it's being run
15 sites across 12 statesFlorida2
New Jersey2
Texas2
Alabama1
Arizona1
California1
Georgia1
Illinois1
Study leadership
- Adrian Wagg · PRINCIPAL_INVESTIGATOR · University of Alberta
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Capture rate following void (captured as % of urine captured by device and collected in canister, measured by weight).From enrollment up to 14 days of treatment
Prior to each nightly use, the weight of the empty urine collection canister and the weight of a dry absorbent pad are collected. Participants use the device overnight while sleeping with the absorbent pad underneath them. The next morning, the post-void weight of the urine collection canister and the post-void weight of the absorbent pad are collected. Capture rate is calculated as the weight of captured urine (post-void canister weight - pre-void canister weight) / total urine volume (captured urine (post-void canister weight - pre-void canister weight) + leaked urine (post-void pad weight - pre-void pad weight)) \* 100.